baber/WOPTO huggingface dataset:
Patent AU-3963993-A (AU)
Title: Potentiation of antimicrobial effects
Inventor: OLUND KARIN
IPC: A61P25/02
Filed: 1993-03-31
Abstract: PCT No. PCT/SE93/00275 Sec. 371 Date Sep. 27, 1994 Sec. 102(e) Date Sep. 27, 1994 PCT Filed Mar. 31, 1993 PCT Pub. No. WO93/20812 PCT Pub. Date Oct. 28, 1993An antimicrobial composition comprising an antimicrobially effective amount of a combination of: A) a monoglyceride of lauric acid, a monoglyceride of monomyristic acid or a mixture of these monoglycerides, and B) at least one chemical substance selected from the following groups: i) local anesthetics of the amide type; ii) carbamide, iii) antibacterial substances in the form of steroid antibiotics, imidazole derivatives or nitroimidazole derivatives, and iv) diols with 3-6 carbon atoms, and C) optionally, a conventional physiologically acceptable carrier and/or physiologically acceptable additives. A process for the preparation of this composition by heating (A) to the transition temperature of the lipid, adding (B), and optionally (C), and cooling the mixture to form a solid lipid crystal composition. Use of the composition for the preparation of a dermatological preparation for combatting bacteria and fungi or as a preservative additive in a cosmetic product, a food product, or a medical product.
Patent AU-4080299-A (AU)
Title: Method for sterilising cereal and leguminous products
Inventor: DELRUE RITA M
IPC: A23B9/02
Filed: 1999-05-14
Abstract: A particulate food product is indirectly heated to at least about 170 DEG  after steam is directly injected onto the particulate food product to provide a moist environment and surface moisture on the particulate food product. The indirect heating is continued for a time and temperature to reduce the microbial contamination of the particulate cereal and/or legume products by an amount of at least log 2 without the loss of the functional properties.
Patent AU-4140389-A (AU)
Title: Novel compounds
Inventor: STEMP GEOFFREY
IPC: C07D311/68
Filed: 1989-09-14
Abstract: Compounds of formula (I) and pharmaceutically acceptable salts thereof: <CHEM>  wherein  a and b together form an -O- or -CH2- linkage or a bond;  either Y is N and R2 is hydrogen; or  Y is C-R1  wherein either one of R1 and R2 is hydrogen and the other is nitro, cyano, halo, CF3, formyl, aldoxime, CF3O, NO2-CH=CH-, NC-CH=CH-; a group RxX- wherein Rx is C1-6 alkyl, aryl or heteroaryl either of which may be optionally substituted by one, two or three of C1-4 alkyl, C1-4 alkoxy, nitro, halo, CF3 and cyano; and X is C=O, O.C=O, C=O.O, CHOH, SO, SO2, O.SO, O.SO2, CONH, O.CONH, C=S, O.C=S, C=S.O, CH.SH, SONH, SO2NH, O.SONH, O.SO2NH, CO-CH=CH, C=NHOH, C=NNH2; or a group RyRzNZ- wherein Ry and Rz are independently hydrogen or C1-6 alkyl and Z is C=O, SO or SO2; or R1 is a C3-8 cycloalkyl group or a C1-6 alkyl group optionally substituted by a group which is hydroxy, C1-6 alkoxy, amino optionally substituted by one or two C1-6 alkyl groups, C1-7 alkanoylamino, C3-8 cycloalkyloxy or C3-8 cycloalkylamino; and R2 is hydrogen; or one of R1 and R2 is nitro, cyano or C1-3 alkylcarbonyl and the other is a different group selected from nitro, cyano, halo, C1-3 alkylcarbonyl, methoxy or amino optionally substituted by one or two C1-6 alkyl or by C2-7 alkanoyl; either one of R3 and R4 is hydrogen or C1-4 alkyl and the other is C1-4 alkyl; or  R3 and R4 together are C2-5 polymethylene;  either R5 is hydrogen, hydroxy, C1-6 alkoxy or C1-7 acyloxy; and  R6 is hydrogen; or  R5 and R6 together are a bond; either R7 is hydrogen, C1-6 alkyl, C3-6 cycloalkyl, C2-6 alkenyl or C2-6 alkynyl; and  R8 is hydrogen or C1-6 alkyl; or  R7 and R8 together are C2-4 polymethylene; R9 is CN, NO2, COR10 or SO2R10 wherein R10 is C1-3 alkyl, NH2, NH(C1-3 alkyl), CF3 or phenyl optionally substituted as defined for Rx; and the R8N(NR9)NHR7 moiety is trans to the R5 group when R5 is hydroxy, C1-6 alkoxy or C1-7 acyloxy; having antihypertensive and/or bronchodilator activity, processes for their preparation and their use as pharmaceuticals.
Patent AU-4200185-A (AU)
Title: Well cementing composition
Inventor: GEORGE CHARLES RAY
IPC: C04B24/16
Filed: 1985-05-06
Abstract: Cement compositions for use in oil, gas and water well cementing operations comprise cement, water and a polymeric additive prepared by caustic-catalyzed condensation of formaldehyde with acetone, or a substance derived from acetone, wherein said polymer includes sodium sulfonate groups in an amount sufficient to render such polymer water soluble. A second fluid loss additive such as hydroxyethyl cellulose, carboxymethylhydroxyethyl cellulose, copolymers of N, N-dimethylacrylamide and 2-acrylamido-2-methyl-propane sulfonic acid or copolymers of acrylamide and 2-acrylamido, 2-methyl-propane sulfonic acid may optinally be included.
Patent AU-4223885-A (AU)
Title: Compositions containing heterocyclic corrosion inhibitors
Inventor: BENTLEY ROBERT LEONARD
IPC: C09D5/08
Filed: 1985-05-09
Abstract: New anticorrosive compositions comprise: (A) an applicational medium selected from (a) surface coatings and (b) wholly or partly aqueous non-coating media, (B) as corrosion inhibitor, an effective corrosion-inhibiting amount of at least one aliphatic or cycloaliphatic mono-, di-, tri- or tetra-carboxylic acid ester or anhydride which is substituted in the aliphatic or cycloaliphatic residue by one or more groups having the formula    <IMAGE>  (I)   in which X is oxygen, sulphur or NH; and each R, independently, is hydrogen, alkyl, haloalkyl, alkoxy, alkylthio, alkylsulphonyl, cycloalkyl, phenyl, alkylphenyl, phenylalkyl, halogen, cyano, nitro, hydroxy, -COOH, -COOalkyl or a primary-, secondary- or tertiary amino- or carbamoyl group; or a non-toxic base addition salts of those components (B) which contain free carboxyl group.
Patent AU-4310700-A (AU)
Title: Polysaccharide structure and sequence determination
Inventor: MARKMAN OFER
IPC: G01N33/53
Filed: 2000-05-04
Abstract: A method for the structural analysis of a saccharide is disclosed, comprising: a) providing on a surface a plurality of essentially sequence- and/or site-specific binding agents; b) contacting said surface with a saccharide to be analyzed, or with a mixture comprising a plurality of fragments of said saccharide; c) washing or otherwise removing unbound saccharide or saccharide fragments; d) adding to the surface obtained in step c) an essentially sequence- and/or site-specific marker, or a mixture of essentially sequence- and/or site-specific markers; e) acquiring one or more images of the markers that are bound to said surface; and f) deriving information related to the identity of the saccharide being analyzed from said image. The invention further provides a solid support comprising in a pre-defined order a plurality of visual or otherwise detectable markers representative of a saccharide or saccharide sequence or fragment, as well as methods and software for choosing a set of essentially sequence-specific markers for use in the method of the invention, methods for obtaining structure-related data of saccharides, and methods and apparatus for analyzing the structure of a saccharide by sequential digestion using a glycosidase or an equivalent thereof.
Patent AU-4438601-A (AU)
Title: Therapeutic combinations of antihypertensive and antiangiogenic agents
Inventor: OGILVIE DONALD JAMES
IPC: A61K31/517
Filed: 2001-04-02
Abstract: The invention concerns the use of a combination of an anti-angiogenic agent and an anti-hypertensive agent for use in the manufacture of a medicament for the treatment of a disease state associated with angiogenesis in a warm-blooded mammal, such as a human being. The invention also relates to pharmaceutical compositions comprising an anti-angiogenic agent and an anti-hypertensive agent, to kits thereof and to a method of treatment of a disease state associated with angiogenesis which comprises the administration of an effective amount of a combination of an anti-angiogenic agent and an anti-hypertensive agent to a warm-blooded animal, such as a human being.
Patent AU-4446093-A (AU)
Title: Process for preparing a polypropylene wax
Inventor: HOHNER GERD
IPC: C08F4/646
Filed: 1993-08-06
Abstract: Polypropylene waxes having good crystallinity and good processing properties can be obtained by solution polymerisation at a temperature above 110 DEG C if the polymerisation is carried out in the presence of a catalyst system prepared from an alkoxymagnesium compound, a tetravalent titanium compound, a silicon compound and an organoaluminium compound. The polypropylene waxes prepared by the process are hard, tough, colourless, non-tacky, thermostable, readily grindable products having an isotacticity, determined by IR spectroscopy, of greater than 70% and a melt viscosity of from 50 to 4000 mPa.s, measured at 170 DEG C. The waxes are suitable, for example, as base materials for pigment preparation, for scratchproofing of printing inks, for matting surface coating materials (paints, lacquers, enamels, varnishes), as assistants (auxiliaries) in the processing of plastics, for example as lubricants and release agents, as a formulation component in phototoners, and as melting point elevators.
Patent AU-4784085-A (AU)
Title: New process for the preparation of derivatives of 4H-1,2,4- triazole, new triazoles so obtained, their use as medicaments and the pharmaceutical compositions containing them
Inventor: CLEMENCE FRANCOIS
IPC: C07D249/08
Filed: 1985-09-24
Abstract: 1. Process for the preparation of compounds of formula (IA ) :  see diagramm : EP0176444,P12,F1  in which R1 , R2 , R3  and R4  identical or different, in whatever position on the benzene nuclei, represent a hydrogen atom, an hydroxyl radical, an alkyl radical containing from 1 to 4 carbon atoms, an Oalk1, radical, alk1  representing an alkyl radical containing from 1 to 4 carbon atoms, an NH2 , NHalk2 radical, alk2 representing an alkyl radical containing from 1 to 4 carbon atoms ; a radical  see diagramm : EP0176444,P12,F2  alk3  and alk'3 , identical or different, representing an alkyl radical containing from 1 to 4 carbon atoms, a halogen atom, a CF3  radical or an NO2  radical, or R1 and R2  and/or R3  and R4  together form a methylenedioxy radical, RA  represents a -CHOH-alk4 radical, or a see diagramm : EP0176444,P12,F3  radical, alk4  and alk5 , identical or different, representing an alkyl radical containing from 1 to 4 carbon atoms, in their racemic or optically active forms, as well as their addition salts with acids characterized in that a compound of formula (II) :  see diagramm : EP0176444,P13,F3  in which R1 , R2 , R3  and R4  have the significances already indicated, is submitted to the action of a chlorination agent so as to obtain an imidyl chloride of formula (III) :  see diagramm : EP0176444,P13,F4  which is submitted to the action of a hydrazide of formula (IV)  see diagramm : EP0176444,P13,F5  in racemic or optically active form, in which Z is a  see diagramm : EP0176444,P13,F6  group, alk4  being an alkyl radical containing from 1 to 4 carbon atoms, so as to obtain a compound of formula (V), in racemic or optically active form :  see diagramm : EP0176444,P13,F7  which is cyclized by heating so as to obtain a compound of formula (I), in racemic or optionally active form, in which R is a  see diagramm : EP0176444,P13,F8  group, which if desired is esterified so as to obtain a product of formula (I) in which RA  is a  see diagramm : EP0176444,P13,F9  group, which products of formula (I) are submitted, if desired, to the cation of an acid so as to form a salt.
Patent AU-4871385-A (AU)
Title: Liposomes of synthetic lipids
Inventor: TARCSAY LAJOS
IPC: A61K9/127
Filed: 1985-10-15
Abstract: The invention relates to pharmaceutical compositions containing synthetic, substantially pure phosphatidyl serine and phosphatidyl choline and a substance or a mixture of substances having biological activity. The invention also relates to mixtures comprising synthetic, substantially pure phosphatidyl serine and phosphatidyl choline, and also to processes for the manufacture of the pharmaecutical compositions, and the use thereof.
Patent AU-4876596-A (AU)
Title: Specific lipid conjugates of nucleoside diphosphates and their use as drugs
Inventor: ZILCH HARALD
IPC: C07H19/10
Filed: 1996-02-15
Abstract: The present invention concerns new phospholipid derivatives of nucleosides of the general formula (I) in which R1 represents a straight-chained or branched, saturated or unsaturated aliphatic residue with 9-14 carbon atoms which can optionally be substituted once or several times; R2 can represent a straight-chained or branched, saturated or unsaturated aliphatic residue with 8-12 carbon atoms which can optionally be substituted once or several times; m is 2 or 3; A can represent a methylene group or an oxygen; Nuc can be a nucleoside or a residue derived from a nucleoside derivative; and tautomers thereof and their physiologically tolerated salts of inorganic and organic acids and bases as well as pharmaceutical preparations containing these compounds.
Patent AU-4886996-A (AU)
Title: An improved artificial airway device
Inventor: O'NEIL MICHAEL JEFFREY
IPC: A61M16/04
Filed: 1996-03-06
Abstract: PCT No. PCT/GB96/00516 Sec. 371 Date Nov. 4, 1997 Sec. 102(e) Date Nov. 4, 1997 PCT Filed Mar. 6, 1996 PCT Pub. No. WO96/27404 PCT Pub. Date Sep. 12, 1996An artificial airway device to facilitate the ventilation of the lungs of an unconscious patient and permitting access to the patient's oesophagus consists of a hollow tube which is left open at both ends having an aperture providing fluid communication between the interior and exterior of said tube disposed at a position between its ends. The tube is provided with an inflatable cuff on one side of the aperture for providing a seal in the patient's pharynx and an inflatable cuff at the end of the tube on the opposite side of the aperture to the inflatable cuff for providing a seal in the patient's oesophagus and also releasably closing the end of the tube.
Patent AU-4964399-A (AU)
Title: Detergent tablet
Inventor: RICCI PATRIZIO
IPC: C11D1/72
Filed: 1999-07-09
Abstract: A multi-phase detergent tablet comprising:   a) a first phase in the form of a shaped body having at least one mould therein; and b) a second phase in the form of a compressed body adhesively contained within said mould, and wherein the second phase comprises an enzyme. The multi-phase tablets provide improved dissolution and cleaning characteristics together with excellent tablet integrity and strength.
Patent AU-5208700-A (AU)
Title: A heat exchanger plate and such a plate with a gasket
Inventor: PETERSEN JES H
IPC: F28F3/10
Filed: 2000-06-14
Abstract: A heat exchanger plate includes a gasket groove that extends through a portion of the plate proximate to the periphery of the plate. The groove includes spaced expanded portions disposed to receive a plurality of coupling elements formed on an associated gasket. The expanded portions include tongue-like ridged portions with openings substantially perpendicular to the longitudinal direction of the gasket groove that are configured to receive the gasket coupling elements.
Patent AU-5247801-A (AU)
Title: Use of chlorhexidine in the prevention of root caries
Inventor: SYMINGTON JOHN M
IPC: A61Q11/00
Filed: 2001-04-03
Abstract: Topical application of a solution of the antimicrobial chlorhexidine to teeth, particularly including exposed root surfaces, prevents the destruction of exposed cementum and associated exposed enamel at the cementum-enamel junction on tooth root surfaces (root caries) and the inflammation of the gingival tissue. In a method of use, a topical solution containing 10% (w/v) chlorhexidine, 20% (w/v) Sumatra benzoin, and 70% (w/v) ethanol is applied to the appropriate area of the tooth surface, followed immediately by application of a sealant which is a solution containing 29% (w/v) medical-grade polyurethane in 49% (w/v) acetone and 22% (w/v) ethyl acetate. Application of the chlorhexidine and sealant to the tooth cementum and gingival margin of "at risk" older adult patients has significantly reduced the prevalence and incidence of root caries and gingival inflammation.
Patent AU-5255190-A (AU)
Title: Isocyanate composition and process for making flexible foams therefrom
Inventor: WATTS ARUN
IPC: C08G101/00
Filed: 1990-04-04
Abstract: The invention relates to a liquid isocyanate-containing prepolymer composition having an average isocyanate functionality greater than 2 and an NCO content of from 2 to 15 % by weight, as obtainable by reacting an isocyanate reactive polymer having an average nominal functionality of from 2 to 6 with a stoichiometric excess of a diphenylmethane diisocyanate composition containing at least 2 % by weight of 2,4'-diphenylmethane diisocyanate and having an average isocyanate functionality in the range from 2 to 2.3. The invention also relates to a method for preparing a polyurethane foam, which comprises reacting such a prepolymer composition with water.
Patent AU-5269290-A (AU)
Title: Process for the manufacture of flame-resistant elastic soft polyurethane foam
Inventor: HEITMANN ULRICH
IPC: C08L75/04
Filed: 1990-03-17
Abstract: A process for producing a flame-resistant elastic soft polyurethane foam from a foam reaction component mixture of a polyol, a polyisocyanate, and a proportion of expanded graphite in the form of flakes as a flame retardant, includes initially admixing the flakes having a size on the order of magnitude of resultant foam cell walls with the polyol component. The flakes are incorporated to form at least part of the cell walls upon expansion of the foam.
Patent AU-5278190-A (AU)
Title: Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
Inventor: SESSLER JONATHAN L
IPC: C07D487/22
Filed: 1990-03-06
Abstract: The present invention involves a novel tripyrrole dimethine-derived "expanded porphyrin" (texaphyrin), the synthesis of such compounds, their analogs or derivatives and their uses. These expanded porphyrin-like macrocycles are efficient chelators of divalent and trivalent metal ions. Metal complexes of these compounds are active as photosensitizers for the generation of singlet oxygen and thus potentially for inactivation or destruction of human immunodeficiency virus (HIV-1), mononuclear or other cells infected with such virus and tumor cells as well. A variety of texaphyrin derivatives have been produced and many more are readily obtainable. Various metal (e.g., transition, main group, and lanthanide) complexes with the texaphyrin and texaphyrin derivatives of the present invention have unusual water solubility and stability which render them particularly useful. These metallotexaphyrin complexes have optical properties making them unique as compared to existing porphyrin-like or other macrocycles. For example, they absorb light strongly in a physiologically important region (i.e. 690-880 nm). These complexes also form long-lived triplet states in high yield and act as efficient photosensitizers for the formation of singlet oxygen. These properties, coupled with their high chemical stability and appreciable solubility in polar media such as water, add to their usefulness.
Patent AU-5394301-A (AU)
Title: Vacuum cleaner filter assembly
Inventor: BERFIELD ROBERT C
IPC: A47L7/00
Filed: 2001-06-20
Abstract: A vacuum cleaner (10) comprising a tank (12); a lid (14) removably attached to the tank (12); a filter support carried by the lid (14), the filter support comprising a shroud (23) depending from the lid (14) defining a central recess (25) and having a bottom wall (24), and a filter cage (26) supported inside the central recess (25); a drain hole (80) formed in the bottom wall (24); and a filter (40) removably attached to the bottom wall (24), the filter (40) including an upper end cap (44); 
wherein the upper end cap (44) of the filter (40) closes off the drain hole (80) when the filter (40) is attached to the shroud (23).
Patent AU-5419190-A (AU)
Title: Angled paving stone
Inventor: BARTH GUNTHER
IPC: E01C9/00
Filed: 1990-04-03
Abstract: PCT No. PCT/EP90/00526 Sec. 371 Date Dec. 3, 1992 Sec. 102(e) Date Dec. 3, 1992 PCT Filed Apr. 3, 1990 PCT Pub. No. WO90/12152 PCT Pub. Date Oct. 18, 1990.An angular paving stone (2) for paving areas, comprising two outer sides (16), two inner sides (18) and two face sides (20). At the five outer corners (4) of the angular paving stone (2) there are provided quarter recesses (22). At the center of the outer sides (16) of the angular paving stone (2) there are provided half recesses (24). At the inner corner (6) of the angular paving stone (2) there is provided a three-quarter recess (26). The partial recesses (22, 24, 26) supplement each other in the paved area so as to form full recesses (38) for water discharge.
Patent AU-5490396-A (AU)
Title: Method for surgically achieving minimum astigmatism measured refractively and topographically
Inventor: ALPINS NOEL AMI
IPC: A61F9/007
Filed: 1996-05-03
Abstract: A method of surgically treating an eye of a patient to correct astigmatism in which values of astigmatism are measured topographically and refractively, and limit values of targeted induced astigmatism for the topographically and refractively measured astigmatism values are obtained by summating the topographically value of astigmatism with the refractive value of astigmatism and vice versa. Respective target values of astigmatism for refraction and topography based on the limit values are obtained and surgical treatment is effected with a target induced astigmatism which is intermediate the limit values and provided respective topographical and refractive non-zero target astigmatism values whose sum is a minimum.
Patent AU-5535090-A (AU)
Title: Novel magnetic resonance imaging agents
Inventor: RAJAGOPALAN RAGHAVAN
IPC: A61K49/06
Filed: 1990-03-12
Abstract: Novel magnetic resonance imaging agents comprise complexes of paramagnetic ions with hydrazide derivatives of polyaminocarboxylic acid chelating agents. These novel imaging agents are characterized by excellent NMR image-contrasting properties and by high solubilities in physiological solutions. A novel method of performing an NMR diagnostic procedure involves administering to a warm-blooded animal an effective amount of a complex as described above and then exposing the warm-blooded animal to an NMR imaging procedure, thereby imaging at least a portion of the body of the warm-blooded animal.
Patent AU-5549590-A (AU)
Title: Temperature-activated adhesive assemblies
Inventor: STEWART RAY F
IPC: C09J7/35
Filed: 1990-04-24
Abstract: Temperature-activated adhesive compositions formulated with crystallizable polymers are provided. The compositions, which display a rapid transition from the tacky to the nontacky state, and/or from the nontacky to the tacky state, are useful in medical applications, where adhesion of a substrate to the skin is desired, as well as in a variety of nonmedical applications. Temperature-activated adhesive assemblies such as tapes, labels, and the like for use in a number of contexts are provided which assemblies have a moisture vapor transmission rate which is compatible with human skin, e.g., above 500 g/m2/day at 37 DEG  C. and a 100% to 10% relative humidity difference.